← Back to Clinical Trials
Recruiting NCT06460012

NCT06460012 Support Via Technology: Living and Learning With Advancing Dementia-REVISED

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06460012
Status Recruiting
Phase
Sponsor Oregon Health and Science University
Condition Caregiver Burden
Study Type INTERVENTIONAL
Enrollment 238 participants
Start Date 2024-07-02
Primary Completion 2026-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
STELLA-R CurriculumUnrestricted AccessLimited Access

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 238 participants in total. It began in 2024-07-02 with a primary completion date of 2026-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

STELLA-R is a multicomponent, self-directed, online intervention designed to facilitate effective management of behavioral and psychological symptoms that are common in many types of dementia. The curriculum instructs care partners to use the ABC approach, a cognitive behavioral technique that teaches care partners to describe a Behavior, then consider the Activators and Consequences of a care recipient behavior. The goal of this intervention is to reduce care partner burden and decrease reactivity to upsetting behaviors.

Eligibility Criteria

Inclusion Criteria: * Adult caring for family member with ADRD * Age of 18 years or older * Speaks and understands English to be able to participate in intervention * Owns a telephone (smartphone, cell phone or landline) * Has email and mailing address to receive study materials and surveys * Provides informed consent to participate in the research * Lives in Oregon, Washington or Idaho * Identifies two or more behavioral symptoms that are distressing to them (care partner) Exclusion Criteria: * Vision problems severe enough to prevent participation * Unwilling or unable to adequately follow study instructions and participate in study procedures

Contact & Investigator

Central Contact

Allison Lindauer, PhD

✉ lindauer@ohsu.edu

📞 (503) 449-8151

Principal Investigator

Allison Lindauer, PhD

PRINCIPAL INVESTIGATOR

Oregon Health and Science University

Frequently Asked Questions

Who can join the NCT06460012 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Caregiver Burden. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06460012 currently recruiting?

Yes, NCT06460012 is actively recruiting participants. Contact the research team at lindauer@ohsu.edu for enrollment information.

Where is the NCT06460012 trial being conducted?

This trial is being conducted at Portland, United States.

Who is sponsoring the NCT06460012 clinical trial?

NCT06460012 is sponsored by Oregon Health and Science University. The principal investigator is Allison Lindauer, PhD at Oregon Health and Science University. The trial plans to enroll 238 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology